目前,急性心肌梗塞(AMI)的诊断主要根据病史、心电图(ECG)和血清酶学检查指标。当ECG出现异常Q波或R波消失,则AMI的诊断无疑,但大约30％尸检证实为AMI的患者无Q波出现。公认的酶学指标CK及CK—MB的灵敏度高达98％,但仍有假阳性。为寻找早期诊断AMI灵敏度高、特异性强的指标,众多学者进行非酶学指标的研究。现就蛋白质检查在AMI诊疗中的应用概述如下。 At present, the diagnosis of acute myocardial infarction (AMI) mainly based on history, electrocardiogram (ECG) and serum enzyme markers. The diagnosis of AMI is undoubtedly made when the abnormal ECG Q wave or R wave disappears, but no Q wave appears in about 30% of patients who have been autopsy confirmed as AMI. The recognized enzymatic indicators CK and CK-MB have a sensitivity of up to 98%, but still have false positives. In order to find the indicators of high sensitivity and specificity of early diagnosis AMI, many scholars do non-enzymatic research. The application of protein test in AMI diagnosis and treatment is summarized as follows.